Fecal Calprotectin: biomarker evidence

Fecal Calprotectin appears in 1 entry of the OSMF biomarker atlas, covering Inflammatory Bowel Disease (Crohn's/UC). Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Inflammatory Bowel Disease (Crohn's/UC)

Where Fecal Calprotectin is reported

ConditionDirectionCompared againstAssociated symptomsSource
Inflammatory Bowel Disease (Crohn's/UC)↑ elevatedIBD patients vs non-IBD/healthy—Tibble et al. 2001

Frequently asked questions

In which conditions is Fecal Calprotectin altered?

In the OSMF atlas Fecal Calprotectin is reported in Inflammatory Bowel Disease (Crohn's/UC). It is elevated in 1 across 1 entries.

Is there a standard clinical test for Fecal Calprotectin?

The atlas entries for Fecal Calprotectin do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Fecal Calprotectin result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Fecal Calprotectin across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/fecal-calprotectin.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.